They might also have a dysfunctional immune responses to infections secondary to immunotherapeutics, such as programmed cell death 1 or programmed cell death ligand 1 inhibitors, or chimeric antigen receptor (CAR)-modified T cell therapy [38]. This evidence concerns the gene CD274 and infection.